or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
antibody PhD Projects, Programmes & Scholarships
We have 24 antibody PhD Projects, Programmes & Scholarships
Virus antigenic evolution under immune pressure
About the Project. The persistent evasion of COVID-19 from vaccines and monoclonal antibody therapeutics underscores the critical need to comprehend how endemic and zoonotic viruses evolve to counter antibody-mediated immune responses. Read more
Resident memory B cell responses in the lung; immunity against pulmonary pathogens
Immunological memory of antibody responses is critical for the ability of the host to cope with secondary infections and is the basis for the development of most current vaccines. Read more
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
Overview. Human cytomegalovirus (HCMV) establishes lifelong infections of the host with >60% infected across the globe. In healthy children and adults HCMV produces mild symptoms like influenza or mononucleosis. Read more
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
Overview. Human cytomegalovirus (HCMV) establishes lifelong infections of the host with >60% infected across the globe. In healthy children and adults HCMV produces mild symptoms like influenza or mononucleosis. Read more
Microneedle delivery systems for next-generation antibody therapeutics
Microneedle arrays are minimally-invasive devices that painlessly, and without drawing blood, penetrate the skin’s stratum corneum barrier. Read more
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens
Universal influenza vaccines are a major global R&D vaccine priority. The Temperton (ORCID. Read more
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens
Universal influenza vaccines are a major global R&D vaccine priority. The Temperton (ORCID. Read more
Nanobody-conjugated graphene based electromechanical biosensors
A nanobody corresponds to a fragment of an camelid antibody (VHH) containing a single monomeric antibody domain. Read more
How does TRIM21 degrade diverse substrates from viruses to neurodegenerative aggregates?
TRIM21 is the cytosolic E3 ligase and antibody receptor responsible for intracellular antibody immunity. Unlike other ubiquitin ligases, TRIM21 doesn’t have a defined substrate but is directed towards its targets by antibodies. Read more
Predicting the Evolution of Influenza and SARS-CoV-2 Viruses
Our research focus is to design and develop analytical, computational, and mathematical methods to understand the fundamental processes that govern the evolution of influenza and SARS-CoV-2 viruses. Read more
Development of integrated microfluidic chips for making mRNA nanomedicines
Project. Messenger RNA (mRNA) provides a highly flexible platform for the development of vaccines. A robust immune response typically requires both an antibody response and a T-cell response. Read more
GW4 BioMed2 MRC DTP PhD project: Targeted protein degradation in CNS disorders
This project is one of a number that are in competition for funding from the GW4 BioMed2 MRC Doctoral Training Partnership which is offering up to 21 studentships for entry in September 2025. Read more
Novel investigation of innate airways defence in Severe Asthma and elucidation of potential therapeutic targets
Research Group:
Wellcome-Wolfson Institute for Experimental Medicine
Join a distinguished translational experimental group that spans from lab work to delivery of specialist asthma clinical care, seeking to understand variation in airways immunity and how this results in varied responses to current asthma therapies. Read more
New therapeutic agents against triple negative breast cancer – targeting an unmet clinical need with the second generation Pol I inhibitor, PMR-116.
This project aims to develop novel therapies for triple-negative breast cancer by combining novel and old drugs to enhance treatment efficacy and reduce side effects. Read more
Function of RNA/DNA hybrids in health and disease
R-loops are non-canonical RNA/DNA structures, formed in all living organisms where they play crucial roles in regulating gene expression, DNA and histone modifications, generation of antibody diversity, DNA replication and genome stability. Read more
- 1
- 2